购物车
- 全部删除
- 您的购物车当前为空
FT113 是口服具有活力的脂肪酸合酶抑制剂,对全长重组人 FASN 酶的 IC50=213 nM。在 BT474 细胞中,它抑制 FASN 的特性,IC50=90 nM。它具有抗增殖作用,在体内和体外实验中,都具有抗癌作用。
为众多的药物研发团队赋能,
让新药发现更简单!
FT113 是口服具有活力的脂肪酸合酶抑制剂,对全长重组人 FASN 酶的 IC50=213 nM。在 BT474 细胞中,它抑制 FASN 的特性,IC50=90 nM。它具有抗增殖作用,在体内和体外实验中,都具有抗癌作用。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 879 | 现货 | |
2 mg | ¥ 1,220 | 现货 | |
5 mg | ¥ 1,650 | 现货 | |
10 mg | ¥ 2,650 | 现货 | |
25 mg | ¥ 4,560 | 现货 | |
50 mg | ¥ 6,390 | 现货 | |
100 mg | ¥ 8,620 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 1,820 | 现货 |
产品描述 | FT113 is a novel potent inhibitor of fatty acid synthase (fasn, IC50 : 213 nM),and exhibits anti-cancer activity |
靶点活性 | Fas:213 nM |
体内活性 | FT113, a compound with potent biochemical and cellular activity, which translated into excellent activity in in vivo models.Caused 32 % and 50% tumor growth inhibition at 25 and 50 mg/kg, respectively in mice. |
动物实验 | Athymic nude mice bearing MV-411 cells. Dosage:5, 25, or 50 mg/kg, twice daily for 16 days |
分子量 | 409.41 |
分子式 | C22H20FN3O4 |
CAS No. | 1630808-89-7 |
Smiles | OC1(CC1)C(=O)N1CCN(CC1)C(=O)c1ccc(cc1)-c1nc2ccc(F)cc2o1 |
密度 | 1.456 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 62.5 mg/mL (152.66 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容